Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
8<br />
1.4 NoCut: preventing the induction of tetraploidy or DNA damage?<br />
The NoCut pathway, initially identified in budding yeast, is thought to protect the chromatin from<br />
abscission-induced DNA damage in yeast 197 . The purpose of NoCut pathway activation seems to differ<br />
between species, since inhibition of the homologues pathway in human cells resulted in tetraploidy<br />
rather than chromatin breakage by the abscission machinery 196 . In addition, we observed that DNA<br />
damage on lagging chromosomes occurs already in telophase, before the induction of abscission<br />
(Chapter 2). RPE cells do elicit an active NoCut response, since we observed localization of several<br />
active NoCut components to the site of abscission in the presence of chromatin bridges (data not<br />
shown). These data together indicate that the NoCut pathway in human cells cannot prevent DNA<br />
damage from occurring during cytokinesis, which suggests that the NoCut pathway in human cells has<br />
indeed primarily been preserved to prevent tetraploidy rather than to inhibit DNA damage induction<br />
on chromatin bridges, as in budding yeast 197 . Interestingly, however, a recent report in which the<br />
abscission mediator ESCRT III was identified as mediator of the NoCut pathway in human cells,<br />
showed that depletion of the ESCRT III subunit CHMP4C resulted in premature chromatin resolution<br />
in anaphase and increased DNA damage 628 , but did not result in overt tetraploidy. This contradiction<br />
raises the question whether the NoCut or abscission checkpoint has been preserved in humans to<br />
protect genome stability by inhibiting DNA damage on lagging chromatin, by inhibiting the formation<br />
of tetraploid cells or both 196,628 .<br />
2. How do chromosome <strong>segregation</strong> <strong>errors</strong> contribute to tumorigenesis?<br />
Boveri was the first to postulate that chromosomal aberrations could be a causal factor in the occurrence<br />
of cancer 232 after von Hansemann had observed the presence of chromosomal abnormalities and<br />
mitotic <strong>errors</strong> in cancer cells 233 . At present, the impact of structural changes on cancer progression<br />
is quite well understood 240 , while the effects of numerical changes on tumorigenesis remain highly<br />
debated 267,398 . Although some of the CIN mouse models develop spontaneous tumors late in life<br />
(Chapter 1), the question remains whether CIN and aneuploidy are causes or consequences of cancer<br />
development.<br />
2.1 Chromosomal instability in tumorigenesis<br />
Chromosomal instability (CIN) has been observed in early neoplastic lesions 629 and is thought to be<br />
able to cause transformation 397,630,631 . In addition, aneuploidy, one of the common consequences of<br />
CIN, can drive evolution by introducing phenotypic variation in several budding yeast strains 632,633 . In<br />
line with a role for CIN in tumorigenesis, CIN has been associated with poor prognosis and resistance<br />
to chemotherapeutics in human patients 271-280 . Indeed, overexpression of the mitotic checkpoint<br />
protein MAD2, which results in CIN 331,332 , has also been shown to be able to drive tumor relapse<br />
in mice following Kras inhibition, indicating that CIN could overcome oncogene-addiction and<br />
affect chemotherapeutic responses 409 . However, not all CIN mouse models develop spontaneous<br />
or carcinogen-driven tumors despite clear aneuploidy induction 295,297,300,412,414,415 . Moreover, CIN has<br />
also been associated with tumor suppression 286,401,404,405 , indicating that the link between CIN and<br />
tumorigenesis remains unclear and that multiple factors likely affect the tumor promoting capacity of<br />
CIN and aneuploidy.<br />
154